Roivant Sciences officer proposes $50.7M share sale

The automatic sale is tied to tax withholding obligations incurred upon the vesting and settlement of equity awards.

Available on EDGAR 11/10/2026 - 05:08 PM EST Accepted by SEC EDGAR 11/10/2026 - 05:08 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Roivant Sciences Ltd. officer Frank M. Torti reported that 1,234,964 common shares are to be sold, with an approximate sale date of November 10, 2026; the listed aggregate market value is $50,732,321.12. The shares were acquired from the issuer as performance stock units for services rendered on November 10, 2026. The sale is described as automatic under an issuer-adopted, mandatory, non-discretionary sell-to-cover arrangement to satisfy tax withholding obligations incurred upon vesting and settlement of equity awards. Morgan Stanley Smith Barney LLC is listed as the broker. Roivant Sciences Ltd. reported 724,561,460 common shares outstanding.

Key Figures

Common shares to be sold: 1,234,964 shares Aggregate market value: $50,732,321.12 Common shares outstanding: 724,561,460 shares +1 more

4 metrics

Common shares to be sold 1,234,964 shares Approximate sale date November 10, 2026

Aggregate market value $50,732,321.12 Shares to be sold

Common shares outstanding 724,561,460 shares Outstanding share count reported

Approximate sale date November 10, 2026 Date listed for the proposed sale

Key Terms

sell-to-cover arrangement, Performance Stock Units, tax withholding obligations

3 terms

sell-to-cover arrangement financial

"mandatory, non-discretionary, sell-to-cover arrangement"

Performance Stock Units financial

"Nature of Acquisition Transaction: Performance Stock Units"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

tax withholding obligations financial

"satisfying tax withholding obligations incurred upon the vesting and settlement"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ROIV shares is Frank M. Torti to sell?

Frank M. Torti, a Roivant Sciences Ltd. officer, is listed as selling 1,234,964 common shares, with an aggregate market value of $50,732,321.12 and an approximate sale date of November 10, 2026.

Why is Frank M. Torti selling ROIV shares?

The sale is automatic under an issuer-adopted, mandatory, non-discretionary sell-to-cover arrangement for satisfying tax withholding obligations incurred upon vesting and settlement of equity awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK	0001647805
Filer CCC	XXXXXXXX
Previous Accession Number Of The Filing	0001950047-26-010935
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer	ROIVANT SCIENCES LTD.
SEC File Number	001-40782
Address of Issuer	50 Broadway London UNITED KINGDOM SW1H 0DB
Phone	44 207 400 3347
Name of Person for Whose Account the Securities are To Be Sold	FRANK M TORTI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1234964	50732321.12	724561460	11/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/10/2026	Performance Stock Units	Issuer			1234964	11/10/2026	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Nothing to Report

144/A: Remarks and Signature

Remarks	We are amending this filing to add the following remarks: The Shares covered by this Form 144 are being sold automatically pursuant to a mandatory, non-discretionary, sell-to-cover arrangement adopted by the Issuer for the purpose of satisfying tax withholding obligations incurred upon the vesting and settlement of equity awards.
Date of Notice	11/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Frank Torti
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)